Beneficial effect of polyherbal formulation in letrozole induced Polycystic ovarian syndrome (PCOS)

10.1016/j.jtcme.2022.08.003

Disha P. Prajapati；Madhavi Patel；Abhay Dharamsi

Polycystic ovarian syndrome ； Letrozole ； Polyherbal formulation ； Clomiphene citrate ； Toxicity

Journal of Traditional and Complementary Medicine

12卷6期（2022 / 11 / 01）

575 - 583

英文

Aim of the study: PCOS is an endocrine condition that results in enlarged ovaries with tiny cysts on the margins. The present study aims to investigate the beneficial effect of polyherbal formulation in Letrozole induced PCOS in female Albino Wistar rats. Materials and methods: Acute toxicity study of the polyherbal formulation by administering a single dose (2000 mg/kg) was done in female Albino Wistar rats (20 weeks, 250 g) following OECD guideline 423. For PCOS induced study female Albino Wistar rats were divided into six groups (6 animals/group). Group I (control) was given 0.5% carboxymethylcellulose (CMC) suspension daily as vehicle control. Letrozole (1 mg/kg) was orally administered for 21 days in Group II to VI for induction of PCOS. After induction of PCOS, animals were treated with standard drug (Group III- Clomiphene citrate- 1 mg/kg) and polyherbal tablets (Group IV - 500 mg/kg, Group V- 750 mg/kg, and Group VI - 1000 mg/kg) up to 50 days. Vaginal smears were taken daily to check the estrous cycle. Body weight was measured weekly. Blood samples were withdrawn on 0,21 and 50 days for the determination of fasting blood glucose, lipid profile, LH, FSH, and hormonal levels. Results: Administration of letrozole caused the abnormality in serum sex hormone profile, lipid profile, glucose, and the estrous cycle. The treatment with polyherbal formulation significantly decreased (P ＜ 0.0001) the level of testosterone and improved estradiol and progesterone levels (P ＜ 0.0001). There was a decrease in elevated glucose levels from 71.51 ± 0.15 mg/dl in disease induced group to 57.33 ± 1.90 mg/dl in treatment groups. The triglycerides level was normalized to 33.41 ± 1.81 mg/dl and HDL level was increased to 40.63 ± 1.35 mg/dl in treatment groups. The polyherbal formulation by exerting its beneficial effect also caused the disappearance of the cysts in the ovaries. Conclusion: The polyherbal formulation was found to be effective in PCOS. The effect may be attributed to the individual herbs reported having a significant effect on the pathophysiology of letrozole induced PCOS.

1. Hosseinkhani, A,Asadi, N,Pasalar, M,Zarshenas, MM(2018).Traditional Persian Medicine and management of metabolic dysfunction in polycystic ovary syndrome.J Tradit Complement Med,8(1),17-23.
   連結：
2. Kakadia, N,Patel, P,Deshpande, S,Shah, G(2019).Effect of Vitex negundo L. seeds in letrozole induced polycystic ovarian syndrome.J Tradit Complement Med,9(4),336-345.
   連結：
3. (2021).Content NPK, Kaempferia OF, Costusigneus LNE.International Journal of Women’s Health,7(5),2-13.
4. Ade, JS,Madgundi, AK(2014).Polycystic ovary syndrome: an ayurvedic perspective W. S. R kriya sharir - review article.Int J Appl Agric Res,1(8),1-5.
5. Azeemuddin, M,Anturlikar, SD,Onkaramurthy, M(2019).Effect of "dXB-2030," a polyherbal formulation, on experimental polycystic ovary syndrome associated with hyperandrogenism.Adv Pharmacol Sci.,2019
6. Basheer, M,Rai, S,Ghosh, H,Ahmad Haja, Y(2018).Protective role of seed extract of Tephrosia purpurea in letrozole induced polycystic ovary syndrome in wistar rats.J Biol Sci.,18(8),458-467.
7. Brandt, LJ,Chey, WD,Foxx-Orenstein, AE,Schiller, LR,Schoenfeld, PS,Spiegel, BM,Talley, NJ,Quigley, EM,American College of Gastroenterology Task Force on Irritable Bowel Syndrome(2009).An evidence-based position statement on the management of irritable bowel syndrome.The American journal of gastroenterology,104,S1-S267.
8. Cibin, TR,Devi, DG,Abraham, A(2012).Chemoprevention of two-stage skin cancer in vivo by Saraca asoca.Integr Cancer Ther,11(3),279-286.
9. Dawane, J,Pandit, V,Khade, K(2017).Study the efficacy of herbal formulation in animal model of polycystic ovarian disease syndrome.Ancient Sci Life,37(2),86-93.
10. Dhiman, K(2014).Ayurvedic intervention in the management of uterine fibroids: a Case series.AYU (An Int Q J Res Ayurveda),35(3),303.
11. Edition F. The Pharmacopoeia of the Pharmacopoeia of. 2016. Published online
12. Hamza, A,Albishri, W,Alfaris, M(2019).Effect of Vitex agnus-castus plant extract on polycystic ovary syndrome complications in experimental rat model.Asian Pacific J Reprod,8(2),63-69.
13. Hassanzadeh Bashtian, M,Ahmad Emami, S,Mousavifar, N,Allah Esmaily, H,Mahmoudi, M,Hooshang Mohammad Poor, A(2013).Evaluation of fenugreek (trigonella foenum-graceum L.). Effects Seeds Extract on Insulin Resistance in Women with Polycystic Ovarian Syndrome.Iran J Pharm Res,12
14. Jadhav, AN,Bhutani, KK(2005).Ayurveda and gynecological disorders.J Ethnopharmacol,97(1),151-159.
15. Jia, L-Y,Feng, J-X,Li, J-L(2021).The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism.Evidence-Based Complementary and Alternative Medicine
16. Kadam, DR,Shinde, DK,Kadam, DR,Kulkarni, DM,Dimple, D(2014).Contemporary and traditional perspectives of polycystic ovarian syndrome (PCOS): a critical review.IOSR J Dent Med Sci.,13(9),89-98.
17. Karole, S,Shrivastava, S,Thomas, S(2019).Therapeutics Polyherbal Formulation Concept for Synergic Action : A Review.Journal of Drug Delivery,9,453-466.
18. Karunagoda, KPKR,Perera, PK,Senanayake, H(2020).Current progress of Ayurveda treatments on uterine fibroids : a comprehensive review.SLJIM,05(25),378-386.
19. Kavitha, A,Babu, AN,Kumar, MS,Kiran, SV(2016).Evaluation of effects of Commiphora wightii in dehydroepiandrosterone (DHEA) induced polycystic ovary syndrome (PCOS) in rats.Pharma,4(1),47-55.
20. Maharjan, R,Nagar, P,Nampoothiri, L(2010).Effect of Aloe barbadensis Mill. Formulation on Letrozole induced polycystic ovarian syndrome rat model.J Ayurveda Integr Med.,1(4),273-279.
21. Mangal, A,Mangal, U(2020).Efficacy of an ayurvedic intervention in the management of polycystic ovarian.Int. J. Ayurveda,8(1),74-76.
22. Mohammadi, A,Gholamhosseinian, A,Fallah, H(2016).Trigonella foenum-graecum water extract improves insulin sensitivity and stimulates PPAR and γ gene expression in high fructose-fed insulin-resistant rats.Adv Biomed Res,5(1),54.
23. Moorthy, R,Prabhu, KM,Murthy, PS(2010).Anti-hyperglycemic compound (gII) from fenugreek (trigonella foenum-graecum linn.) seeds, its purification and effect in diabetes mellitus.Indian J Exp Biol,48(11),1111-1118.
24. Nagarathna, PKM,Rajan, PR,Koneri, R(2013).A detailed study on poly cystic ovarian syndrome and it's treatment with natural products.Int J Toxicol Pharmacol Res,5(4),109-120.
25. National Institutes of Health. Polycystic ovary/ovarian syndrome (PCOS). Natl Inst Heal. Published online. 2019:1-13.
26. Orio, F,Muscogiuri, G,Palomba, S(2013).Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity.ESP J,8(5),e200-e204.
27. Pandit, RK,Suresh, K(1992).Kanchnar guggulueA critical review.J Res Educ Indian Med,11,39-42.
28. Parasuraman, S,Thing, GS,Dhanaraj, SA(2014).Polyherbal formulation: concept of ayurveda.Pharm Rev,8(16),4-8.
29. Pena, AS,Witchel, SF,Hoeger, KM(2020).Adolescent polycystic ovary syndrome according to the international evidence-based guideline.BMC Med,18(1),1-16.
30. Pm, G,Pd, P(2017).Concept of polycystic ovarian syndrome: perspectives of Ayurveda and modern science.Int J Pharmacogn Phytochem Res,9(10),1363-1372.
31. Prajapati, D,Patel, M,Dharamsi, A(2022).Development and evaluation of a polyherbal tablet for polycystic ovarian syndrome (PCOS).J Nat Remedies,22(2),161.
32. R, S,P, H(2010).Alternative therapies in polycystic ovarian syndrome.Insulin,1(2),3.
33. Rajkapoor, B,Jayakar, B,Murugesh, N,Dhiman, K(2014).Ayurvedic intervention in the management of uterine fibroids: a Case series.AYU (An Int Q J Res Ayurveda),35(3),303.
34. Rajurker, S,Rekhe, DS,Maini, S,Ravikanth, K(2009).Acute toxicity studies of polyherbal formulation (Methiorep Premix).Vet World,2(2),58-59.
35. Razzaq, FA,Khan, RA,Feroz, Z,Afroz, S(2011).Effect of Berberis aristata on lipid profile and coagulation parameters.African J Pharm Pharmacol,5(7),943-947.
36. Reddy, PS,Begum, N,Mutha, S,Bakshi, V(2016).Beneficial effect of Curcumin in Letrozole induced polycystic ovary syndrome.Asian Pacific J Reprod,5(2),116-122.
37. Renuka, C,Ramesh, N,Saravanan, K(2009).Evaluation of the antidiabetic effect of Trigonella foenum-graecumseed powder on alloxan-induced diabetic albino rats.Int J PharmTech Res,1(4),41580-1584.
38. Rondanelli, M,Infantino, V,Riva, A(2020).Polycystic ovary syndrome management: a review of the possible amazing role of berberine.Arch Gynecol Obstet,301,53-60.
39. Sarang Deshpande, DSD(2013).Effect of polyherbal formulation in treatment of poly cystic ovarian syndrome (PCOS).IOSR J Pharm Biol Sci.,5(5),63-66.
40. Shahid, AP,Salini, S,Sasidharan, N,Padikkala, J,Raghavamenon, AC,Babu, TD(2015).Effect of Saraca asoca (Asoka) on estradiol-induced keratinizing metaplasia in rat uterus.J Basic Clin Physiol Pharmacol,26(5),509-515.
41. Shi, D,Vine, DF(2012).Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.Fertil Steril,98(1),185-193.
42. Sidhu, GS,Mani, H,Gaddipati, JP(1999).Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice.Wound Repair Regen,7(5),362-374.
43. Swar, G,Shailajan, S,Menon, S(2017).Activity based evaluation of a traditional Ayurvedic medicinal plant: Saraca asoca (Roxb.) de Wilde flowers as estrogenic agents using ovariectomized rat model.J Ethnopharmacol,195,324-333.
44. Tamadon, A,Hu, W,Cui, P(2018).How to choose the suitable animal model of polycystic ovary syndrome?.Tradit Med Mod Med,95-113.
45. Teede, H,Misso, M,Costello, M(2018).International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2018.
46. Trinkley, KE,Nahata, MC(2014).Medication management of irritable bowel syndrome.Digestion,89(4),253-267.
47. Upwar, N,Patel, R,Waseem, N,Mahobia, NK(2011).Hypoglycemic effect of methanolic extract of Berberis aristata DC stem on normal and streptozotocin induced diabetic rats.Int J Pharm Pharmaceut Sci,3(1),222-224.
48. Witchel, SF,Oberfield, SE,Peña, AS(2019).Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls.J Endocr Soc.,3(8),1545-1573.
49. Woo J, Scott RK. 18-18 : Polycystic Ovary Syndrome. Published online 2021: 2020-2021.
50. Zhang, Y,Guo, X,Ma, S(2021).The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome.Evidence-Based Complementary and Alternative Medicine